Alambic Investment Management, L.P. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2018$77,000
-87.5%
35,665
-71.2%
0.06%
-63.9%
Q2 2018$617,000–123,976–0.17%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2018.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders